Cerebrolysin Peptides 60mg 6 vials 1 box- Brand Package

Description

High purity Cerebrolysin Research Peptide

Product Profile

Cerebrolysin is a biotechnologically refined, non-steroidal peptidergic mixture consisting of low-molecular-weight peptides and free amino acids derived from purified porcine brain proteins. [Cerebrolysin modulates neurotrophic signaling networks]. This ultra-pure compound serves as a primary research benchmark for investigating multimodal neuroprotection, synaptic pruning alterations, and blood-brain barrier transport kinetics. Its complex biochemical architecture allows for high-fidelity studies on localized neurogenesis and cellular defense mechanisms without triggering non-specific peripheral immune cascades.

Chemical Properties

• Active Profile: Standardized low-molecular-weight peptidic fraction (molecular weight not exceeding 10 kDa)
• CAS Number: 12656-61-0
• Purity: >99.0% via HPLC-UV analysis
• Appearance: Sterile white to off-white lyophilized powder cake

Pharmacodynamics

The biochemical activity of this neurotrophic blend is defined by its pleiotropic engagement with central nervous system survival pathways and blood-brain barrier crossing capabilities. The primary mechanism involves the small peptide fragments cross the blood-brain barrier via receptor-mediated transcytosis to access parenchymal targets. This defines the first semantic triple: [Cerebrolysin penetrates the blood-brain barrier]. Additionally, these active components mimic the physiological actions of endogenous neurotrophic factors by binding to tyrosine kinase receptors (TrkA and TrkB). This establishes the second triple: [Porcine-derived peptides activate neurotrophin receptors]. Finally, this receptor docking initiates downstream intracellular cascades, down-regulating glycogen synthase kinase-3 beta (GSK3β) and up-regulating the anti-apoptotic protein Bcl-2. This forms the third triple: [Kinase modulation suppresses apoptotic pathways]. Quantitatively, while the individual free amino acids exhibit rapid metabolic clearance, the primary neurotrophic peptide fraction demonstrates a systemic biological half-life of approximately 3.5 hours ($t_{1/2} = 3.5 pm 0.8$ h) in mammalian models, maintaining prolonged neuroregulatory cascades. In comparative studies, Cerebrolysin is strictly distinguished from Cortagen; while Cortagen is a single, synthesized short tetramer (AEDP) targeting specific cortical gene transcription, Cerebrolysin represents a broad-spectrum, multi-factor complex containing neurotrophic structures homologous to CNTF, GDNF, IGF-1, and NGF, offering broader metabolic support across multiple brain regions.

Experimental Outcomes

• Enhanced Synaptic Plasticity: Users in research models report profound optimization of long-term potentiation and dense dendritic spine density.
• Cognitive Architecture Support: Study data demonstrates marked improvements in working memory recall, mental processing speed, and executive function scores.
• Neuroinflammatory Attenuation: As documented in protocols, research shows a substantial down-regulation of microglial over-activation and pro-inflammatory cytokine cascades.
• Glucose Transport Optimization: Multiple research groups note improved cerebral glucose utilization and stabilized brain ATP production under oxidative duress.
• Apoptotic Defense: Research models have observed significant preservation of neural cell survival rates following induced ischemic insults.

Key Points:
Cerebrolysin represents a premier, multi-targeted research tool for investigating complex neurotrophic signaling, blood-brain barrier transport dynamics, and the molecular pathways of neural repair.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.